Summary

The global Direct Agglutination Test market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Direct Agglutination Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Direct Agglutination Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Direct Agglutination Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Direct Agglutination Test players cover Atlas Medical GmbH, Thermo Fisher Scientific, Bio-Rad, HiMedia, Pro Lab, Arlington Scientific, Hardy Diagnostics, Liofilchem S.r.l and Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The Direct Agglutination Test (DAT) is a diagnostic test used in immunology to detect antibodies or antigens in a patient's sample, typically blood or other body fluids. It is commonly used to diagnose and monitor infectious diseases caused by certain pathogens, especially those that induce antibody production.

LPI (LP Information)' newest research report, the “Direct Agglutination Test Industry Forecast” looks at past sales and reviews total world Direct Agglutination Test sales in 2022, providing a comprehensive analysis by region and market sector of projected Direct Agglutination Test sales for 2023 through 2029. With Direct Agglutination Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Direct Agglutination Test industry.
This Insight Report provides a comprehensive analysis of the global Direct Agglutination Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Direct Agglutination Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Direct Agglutination Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Direct Agglutination Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Direct Agglutination Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Direct Agglutination Test market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Blood
Urine
Escherichia Coli
Others
Segmentation by application
Clinics
Hospital
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Atlas Medical GmbH
Thermo Fisher Scientific
Bio-Rad
HiMedia
Pro Lab
Arlington Scientific
Hardy Diagnostics
Liofilchem S.r.l
Biotec

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Direct Agglutination Test Market Size 2018-2029
2.1.2 Direct Agglutination Test Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Direct Agglutination Test Segment by Type
2.2.1 Blood
2.2.2 Urine
2.2.3 Escherichia Coli
2.2.4 Others
2.3 Direct Agglutination Test Market Size by Type
2.3.1 Direct Agglutination Test Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Direct Agglutination Test Market Size Market Share by Type (2018-2023)
2.4 Direct Agglutination Test Segment by Application
2.4.1 Clinics
2.4.2 Hospital
2.4.3 Other
2.5 Direct Agglutination Test Market Size by Application
2.5.1 Direct Agglutination Test Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Direct Agglutination Test Market Size Market Share by Application (2018-2023)
3 Direct Agglutination Test Market Size by Player
3.1 Direct Agglutination Test Market Size Market Share by Players
3.1.1 Global Direct Agglutination Test Revenue by Players (2018-2023)
3.1.2 Global Direct Agglutination Test Revenue Market Share by Players (2018-2023)
3.2 Global Direct Agglutination Test Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Direct Agglutination Test by Regions
4.1 Direct Agglutination Test Market Size by Regions (2018-2023)
4.2 Americas Direct Agglutination Test Market Size Growth (2018-2023)
4.3 APAC Direct Agglutination Test Market Size Growth (2018-2023)
4.4 Europe Direct Agglutination Test Market Size Growth (2018-2023)
4.5 Middle East & Africa Direct Agglutination Test Market Size Growth (2018-2023)
5 Americas
5.1 Americas Direct Agglutination Test Market Size by Country (2018-2023)
5.2 Americas Direct Agglutination Test Market Size by Type (2018-2023)
5.3 Americas Direct Agglutination Test Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Direct Agglutination Test Market Size by Region (2018-2023)
6.2 APAC Direct Agglutination Test Market Size by Type (2018-2023)
6.3 APAC Direct Agglutination Test Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Direct Agglutination Test by Country (2018-2023)
7.2 Europe Direct Agglutination Test Market Size by Type (2018-2023)
7.3 Europe Direct Agglutination Test Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Direct Agglutination Test by Region (2018-2023)
8.2 Middle East & Africa Direct Agglutination Test Market Size by Type (2018-2023)
8.3 Middle East & Africa Direct Agglutination Test Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Direct Agglutination Test Market Forecast
10.1 Global Direct Agglutination Test Forecast by Regions (2024-2029)
10.1.1 Global Direct Agglutination Test Forecast by Regions (2024-2029)
10.1.2 Americas Direct Agglutination Test Forecast
10.1.3 APAC Direct Agglutination Test Forecast
10.1.4 Europe Direct Agglutination Test Forecast
10.1.5 Middle East & Africa Direct Agglutination Test Forecast
10.2 Americas Direct Agglutination Test Forecast by Country (2024-2029)
10.2.1 United States Direct Agglutination Test Market Forecast
10.2.2 Canada Direct Agglutination Test Market Forecast
10.2.3 Mexico Direct Agglutination Test Market Forecast
10.2.4 Brazil Direct Agglutination Test Market Forecast
10.3 APAC Direct Agglutination Test Forecast by Region (2024-2029)
10.3.1 China Direct Agglutination Test Market Forecast
10.3.2 Japan Direct Agglutination Test Market Forecast
10.3.3 Korea Direct Agglutination Test Market Forecast
10.3.4 Southeast Asia Direct Agglutination Test Market Forecast
10.3.5 India Direct Agglutination Test Market Forecast
10.3.6 Australia Direct Agglutination Test Market Forecast
10.4 Europe Direct Agglutination Test Forecast by Country (2024-2029)
10.4.1 Germany Direct Agglutination Test Market Forecast
10.4.2 France Direct Agglutination Test Market Forecast
10.4.3 UK Direct Agglutination Test Market Forecast
10.4.4 Italy Direct Agglutination Test Market Forecast
10.4.5 Russia Direct Agglutination Test Market Forecast
10.5 Middle East & Africa Direct Agglutination Test Forecast by Region (2024-2029)
10.5.1 Egypt Direct Agglutination Test Market Forecast
10.5.2 South Africa Direct Agglutination Test Market Forecast
10.5.3 Israel Direct Agglutination Test Market Forecast
10.5.4 Turkey Direct Agglutination Test Market Forecast
10.5.5 GCC Countries Direct Agglutination Test Market Forecast
10.6 Global Direct Agglutination Test Forecast by Type (2024-2029)
10.7 Global Direct Agglutination Test Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Atlas Medical GmbH
11.1.1 Atlas Medical GmbH Company Information
11.1.2 Atlas Medical GmbH Direct Agglutination Test Product Offered
11.1.3 Atlas Medical GmbH Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Atlas Medical GmbH Main Business Overview
11.1.5 Atlas Medical GmbH Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Direct Agglutination Test Product Offered
11.2.3 Thermo Fisher Scientific Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Information
11.3.2 Bio-Rad Direct Agglutination Test Product Offered
11.3.3 Bio-Rad Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bio-Rad Main Business Overview
11.3.5 Bio-Rad Latest Developments
11.4 HiMedia
11.4.1 HiMedia Company Information
11.4.2 HiMedia Direct Agglutination Test Product Offered
11.4.3 HiMedia Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 HiMedia Main Business Overview
11.4.5 HiMedia Latest Developments
11.5 Pro Lab
11.5.1 Pro Lab Company Information
11.5.2 Pro Lab Direct Agglutination Test Product Offered
11.5.3 Pro Lab Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Pro Lab Main Business Overview
11.5.5 Pro Lab Latest Developments
11.6 Arlington Scientific
11.6.1 Arlington Scientific Company Information
11.6.2 Arlington Scientific Direct Agglutination Test Product Offered
11.6.3 Arlington Scientific Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Arlington Scientific Main Business Overview
11.6.5 Arlington Scientific Latest Developments
11.7 Hardy Diagnostics
11.7.1 Hardy Diagnostics Company Information
11.7.2 Hardy Diagnostics Direct Agglutination Test Product Offered
11.7.3 Hardy Diagnostics Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Hardy Diagnostics Main Business Overview
11.7.5 Hardy Diagnostics Latest Developments
11.8 Liofilchem S.r.l
11.8.1 Liofilchem S.r.l Company Information
11.8.2 Liofilchem S.r.l Direct Agglutination Test Product Offered
11.8.3 Liofilchem S.r.l Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Liofilchem S.r.l Main Business Overview
11.8.5 Liofilchem S.r.l Latest Developments
11.9 Biotec
11.9.1 Biotec Company Information
11.9.2 Biotec Direct Agglutination Test Product Offered
11.9.3 Biotec Direct Agglutination Test Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Biotec Main Business Overview
11.9.5 Biotec Latest Developments
12 Research Findings and Conclusion